Literature DB >> 11867711

Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.

Richard Nass1, David H Hall, David M Miller, Randy D Blakely.   

Abstract

Parkinson's disease is a complex neurodegenerative disorder characterized by the death of brain dopamine neurons. In mammals, dopamine neuronal degeneration can be triggered through exposure to neurotoxins accumulated by the presynaptic dopamine transporter (DAT), including 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium. We have established a system for the pharmacological and genetic evaluation of neurotoxin-induced dopamine neuronal death in Caenorhabditis elegans. Brief (1 h) exposure of green fluorescent protein-tagged, living worms to 6-OHDA causes selective degeneration of dopamine neurons. We demonstrate that agents that interfere with DAT function protect against 6-OHDA toxicity. 6-OHDA-triggered neural degeneration does not require the CED-3/CED-4 cell death pathway, but is abolished by the genetic disruption of the C. elegans DAT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867711      PMCID: PMC122507          DOI: 10.1073/pnas.042497999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

2.  Dopaminergic neurons in the nematode Caenorhabditis elegans.

Authors:  J Sulston; M Dew; S Brenner
Journal:  J Comp Neurol       Date:  1975-09-15       Impact factor: 3.215

Review 3.  Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors.

Authors:  V M Pickel; M J Nirenberg; T A Milner
Journal:  J Neurocytol       Date:  1996-12

4.  UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans.

Authors:  A R Winnier; J Y Meir; J M Ross; N Tavernarakis; M Driscoll; T Ishihara; I Katsura; D M Miller
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

5.  Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.

Authors:  J M Van Kampen; E G McGeer; A J Stoessl
Journal:  Synapse       Date:  2000-09-01       Impact factor: 2.562

6.  Control of C. elegans larval development by neuronal expression of a TGF-beta homolog.

Authors:  P Ren; C S Lim; R Johnsen; P S Albert; D Pilgrim; D L Riddle
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

8.  Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.

Authors:  K Jellinger; L Linert; E Kienzl; E Herlinger; M B Youdim
Journal:  J Neural Transm Suppl       Date:  1995

Review 9.  Oxidative mechanisms in nigral cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  156 in total

Review 1.  Target discovery and validation in the post-genomic era.

Authors:  Steven P Butcher
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

2.  Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.

Authors:  Violetta N Pivtoraiko; Adam J Harrington; Burton J Mader; Austin M Luker; Guy A Caldwell; Kim A Caldwell; Kevin A Roth; John J Shacka
Journal:  J Neurochem       Date:  2010-06-01       Impact factor: 5.372

Review 3.  A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.

Authors:  Paige M Dexter; Kim A Caldwell; Guy A Caldwell
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

Authors:  Roongpetch Keowkase; Marwa Aboukhatwa; Yuan Luo
Journal:  Neuropharmacology       Date:  2010-04-24       Impact factor: 5.250

5.  New alleles of the lin-22/Hairy bHLH transcription factor.

Authors:  Maria Doitsidou; Oliver Hobert
Journal:  MicroPubl Biol       Date:  2019-04-19

6.  MANF deletion abrogates early larval Caenorhabditis elegans stress response to tunicamycin and Pseudomonas aeruginosa.

Authors:  Jessica H Hartman; Christopher T Richie; Kacy L Gordon; Danielle F Mello; Priscila Castillo; April Zhu; Yun Wang; Barry J Hoffer; David R Sherwood; Joel N Meyer; Brandon K Harvey
Journal:  Eur J Cell Biol       Date:  2019-05-21       Impact factor: 4.492

7.  Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Authors:  Sudipta Chakraborty; Pan Chen; Julia Bornhorst; Tanja Schwerdtle; Fabian Schumacher; Burkhard Kleuser; Aaron B Bowman; Michael Aschner
Journal:  Metallomics       Date:  2015-03-13       Impact factor: 4.526

8.  Genetic analysis of KillerRed in C. elegans identifies a shared role of calcium genes in ROS-mediated neurodegeneration.

Authors:  Lyndsay E A Young; Chelsea Shoben; Kyra Ricci; Daniel C Williams
Journal:  J Neurogenet       Date:  2018-11-29       Impact factor: 1.250

9.  Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Authors:  Marketa Marvanova; Charles D Nichols
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  Haloperidol Interactions with the dop-3 Receptor in Caenorhabditis elegans.

Authors:  Bárbara Nunes Krum; Airton C Martins; Libânia Queirós; Beatriz Ferrer; Ginger L Milne; Félix Alexandre Antunes Soares; Roselei Fachinetto; Michael Aschner
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.